Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

GT Biopharma Inc. (GTBP)

  • Technical Exchange News
  • Nov. 30, 2024, 03:15 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 30, 2024, 03:15 UTC
  • 46
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 30, 2024, 03:15 UTC
  • 50
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Imac Holdings Inc (BACK)

  • Technical Exchange News
  • Nov. 30, 2024, 03:15 UTC
  • 49
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Deficient and Delinquent.

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Technical Exchange News
  • Nov. 30, 2024, 03:15 UTC
  • 48
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Scilex Holding Co (SCLX)

  • Technical Exchange News
  • Nov. 29, 2024, 18:51 UTC
  • 48
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Deficient and Delinquent.

Comment Full text

Quanterix Corp (QTRX)

  • Technical Exchange News
  • Nov. 29, 2024, 18:51 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

GT Biopharma Inc. (GTBP)

  • Technical Exchange News
  • Nov. 29, 2024, 18:50 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Nov. 29, 2024, 18:50 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Nov. 29, 2024, 18:50 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190383)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124842)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin